In this article

CVS

Follow your favorite stocks CREATE FREE ACCOUNT

CVS Health on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.

Shares of CVS, which operates one of the largest U.S. pharmacy chains, rose 2.4% to $78.38 in premarket trading, after the company also raised its 2025 profit outlook for the fourth time.

The upbeat outlook caps a year in which CEO David Joyner pushed through a much-needed and sweeping overhaul, including cost-cutting measures, exits from underperforming markets and strengthening top management to revive investor confidence.

The efforts have helped restore investor confidence in the company, with CVS shares surging 70.5% so far th

See Full Page